Teva to lose grip on Copaxone next year

20-11-2013

Teva to lose grip on Copaxone next year

The US Supreme Court has refused a request from Teva to stay an appeals court order, meaning the pharmaceutical company will lose exclusivity on Copaxone in May next year, rather than in 2015.


Teva, Copaxone, patent exclusivity, US Supreme Court

LSIPR